You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Lymphoplasmacytoid

Showing 1 - 25 of 5,080
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

Completed
  • NHL
  • +17 more
  • veltuzumab
  • Savannah, Georgia
  • +4 more
Aug 12, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

Terminated
  • Chronic Lymphocytic Leukemia
  • +7 more
  • Orange, California
  • +10 more
Oct 15, 2020

Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)

Active, not recruiting
  • Lymphoma, Follicular
  • +2 more
  • FCM
  • +3 more
  • Munich, Germany
    German Low Grade Study Group (Glsg)
May 6, 2021

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Obinutuzumab in Chinese Real-world Patients With iNHL

Not yet recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Changzhou, Jiangsu, China
  • +24 more
Jul 23, 2023

Hematological Malignancies - SANGUINE

Recruiting
  • Hematologic Malignancy
  • Blood sampling for HemaChip screening/diagnostic testing
  • Bone marrow sampling
  • Olomouc, Czechia
  • +3 more
Feb 9, 2023

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

Recruiting
  • Hematologic Malignancies
  • Torrance, California
  • +51 more
Jan 12, 2023

Mantle Cell Lymphoma Trial in China (High dose, Low dose)

Not yet recruiting
  • Mantle Cell Lymphoma
  • High dose
  • Low dose
  • Bengbu, Anhui, China
  • +20 more
Jul 28, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow

Not yet recruiting
  • Lymphoma
  • positron emission tomography for exclusion of bone marrow infiltration in lymphoma
  • (no location specified)
Oct 28, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

Recruiting
  • Diffuse Large B-cell Lymphoma Recurrent
  • Diffuse Large B Cell Lymphoma Refractory
  • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 12, 2023

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

    Completed
    • Follicular Lymphoma
    • +3 more
    • Angers, France
    • +24 more
    Jan 9, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

    Recruiting
    • Relapsed or Refractory B-cell Lymphoma
    • +6 more
    • Beijing, China
      Beijing Cancer Hospital
    Feb 6, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Lymphoma, B-Cell Trial in Belgium, France (Valemetostat tosylate)

    Recruiting
    • Lymphoma, B-Cell
    • Valemetostat tosylate
    • Bruges, Belgium
    • +21 more
    Jan 9, 2023